表紙
市場調査レポート

血友病B:世界の治験レビュー

Hemophilia B Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 212846
出版日 ページ情報 英文 93 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
血友病B:世界の治験レビュー Hemophilia B Global Clinical Trials Review, H2, 2014
出版日: 2014年12月31日 ページ情報: 英文 93 Pages
概要

当レポートでは、血友病Bの臨床試験に関連する基本情報やデータを提供しており、試験件数および被験者の募集状況、段階別の動向、臨床試験を実施している主な製薬企業および研究機関のプロファイルなどをまとめています。

イントロダクション

  • 血友病B
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国における治験件数
    • 欧州の主要5ヶ国における治験件数
    • 北米の主要国における治験件数
    • 中東・アフリカの主要5カ国における治験件数
    • 中南米の主要5カ国における治験件数

G7諸国での治験件数:血液疾患の治験における血友病Bの割合

G7諸国における段階別の治験件数

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:血液疾患の治験における血友病Bの割合

E7諸国における段階別の治験件数

E7諸国での治験件数:進捗状況別

段階別の治験件数

  • 進行中の治験:段階別

進捗状況別の治験件数

治験の目標の達成状況

未完了の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

血友病B治療薬の治験に携わっている主要企業

有望な薬剤

血友病B関連の最新の治験ニュース

治験のプロファイル

  • 主要企業の治験の概要
    • Novo A/S
    • Pfizer Inc.
    • CSL Limited
    • Baxter International Inc.
    • Biogen Idec Inc.
    • Bio Products Laboratory Ltd.
    • Emergent BioSolutions Inc.
    • uniQure N.V.
    • Kaketsuken K.K.
    • Bayer AG
  • 代表的な研究機関・病院の治験の概要
    • Weill Cornell Medical College
    • National Center for Research Resources
    • NewYork- Presbyterian Hospital
    • University of Sao Paulo General Hospital
    • Azienda Ospedaliero-Universitaria Careggi
    • Tokyo Medical University
    • Sapienza University of Rome
    • Virginia Commonwealth University
    • Cliniques Universitaires Saint-Luc

5つの代表的な治験のプロファイル

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2515CTIDB

GlobalData's clinical trial report, "Hemophilia B Global Clinical Trials Review, H2, 2014" provides data on the Hemophilia B clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hemophilia B. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hemophilia B. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hemophilia B
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hemophilia B to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hemophilia B to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hemophilia B
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hemophilia B Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Hemophilia B
    • Dec 17, 2014: LFB Announces Achievement of Patient Enrollment Target for PerSept 1 Program for the Evaluation of Recombinant Factor Seven Efficacy by Prospective Clinical Trials
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novo A/S
      • Clinical Trial Overview of Novo A/S
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • Baxter International Inc.
      • Clinical Trial Overview of Baxter International Inc.
      • Biogen Idec Inc.
      • Clinical Trial Overview of Biogen Idec Inc.
      • Bio Products Laboratory Ltd.
      • Clinical Trial Overview of Bio Products Laboratory Ltd.
      • Emergent BioSolutions Inc.
      • Clinical Trial Overview of Emergent BioSolutions Inc.
      • uniQure N.V.
      • Clinical Trial Overview of uniQure N.V.
      • Kaketsuken K.K.
      • Clinical Trial Overview of Kaketsuken K.K.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
    • Clinical Trial Overview of Top Institutes / Government
      • Weill Cornell Medical College
      • Clinical Trial Overview of Weill Cornell Medical College
      • National Center for Research Resources
      • Clinical Trial Overview of National Center for Research Resources
      • NewYork- Presbyterian Hospital
      • Clinical Trial Overview of NewYork- Presbyterian Hospital
      • University of Sao Paulo General Hospital
      • Clinical Trial Overview of University of Sao Paulo General Hospital
      • Azienda Ospedaliero-Universitaria Careggi
      • Clinical Trial Overview of Azienda Ospedaliero-Universitaria Careggi
      • Tokyo Medical University
      • Clinical Trial Overview of Tokyo Medical University
      • Sapienza University of Rome
      • Clinical Trial Overview of Sapienza University of Rome
      • Virginia Commonwealth University
      • Clinical Trial Overview of Virginia Commonwealth University
      • Cliniques Universitaires Saint-Luc
      • Clinical Trial Overview of Cliniques Universitaires Saint-Luc
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hemophilia B Therapeutics, Global, Clinical Trials by Region, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Hemophilia B Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Hemophilia B to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hemophilia B to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hemophilia B Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Hemophilia B Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Hemophilia B Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hemophilia B Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter International Inc., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Biogen Idec Inc., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Bio Products Laboratory Ltd., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Emergent BioSolutions Inc., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by uniQure N.V., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaketsuken K.K., 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by National Center for Research Resources, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by NewYork- Presbyterian Hospital, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo General Hospital, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliero-Universitaria Careggi, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Tokyo Medical University, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Virginia Commonwealth University, 2014*
  • Hemophilia B Therapeutics Clinical Trials Market, Global, Clinical Trials by Cliniques Universitaires Saint-Luc, 2014*

List of Figures

  • Hemophilia B Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Hemophilia B Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Hemophilia B Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Hemophilia B Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Hemophilia B Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Hemophilia B to Hematological Disorders Clinical Trials, G7 Countries (%), 2014*
  • Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Hemophilia B Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Hemophilia B to Hematological Disorders Clinical Trials, E7 Countries (%), 2014*
  • Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Hemophilia B Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Hemophilia B Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Hemophilia B Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Hemophilia B Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top